- ►angrylapdog.com J Weissberg-Benchell, J Antisdel-Lomaglio, R … - Diabetes Care, 2003 - care.diabetesjournals.org.p.angrylapdog.com RESEARCH DESIGN AND METHODS—Studies were identified and data regarding study
design, year of publication, sample size, patient's age, diabetes duration, and
duration of CSII therapy were collected. Means and SDs for glycohemoglobin, ... Cited by 294 - Related articles - BL Direct - All 14 versions
- ►bmj.com J Pickup, M Mattock, S Kerry - British Medical Journal, 2002 - bmj.com Continuous subcutaneous insulin infusion, often called insulin pump therapy, was
introduced in the 1970s as a way of achieving and maintaining strict control of
blood glucose concentrations in people with type 1 (insulin dependent) ... Cited by 256 - Related articles - BL Direct - All 10 versions
J Pickup, H Keen - Diabetes care, 2002 - Am Diabetes Assoc Continuous subcutaneous insulin infusion (CSII) is used in selected type 1
diabetic subjects to achieve strict blood glucose control. A quarter of a
century after its introduction, world-wide use of CSII is increasing. We ... Cited by 223 - Related articles - BL Direct - All 8 versions
- ►diabetesjournals.org LP Plotnick, LM Clark, FL Brancati, T Erlinger - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—There was a small but significant decrease in HbA 1c at 3–6 months
after pump start (7.7 vs. 7.5%; P = 0.03). HbA 1c levels then gradually
increased and remained elevated after 1 year of follow-up; however, this ... Cited by 146 - Related articles - BL Direct - All 10 versions
- ►input.me.uk [PDF] N Weintrob, H Benzaquen, A Galatzer, S … - Pediatrics, 2003 - Am Acad Pediatrics Results. The changes in HbA 1c and fructoseamine values were similar in the 2
arms over time. At the end of the study, mean HbA 1c level measured 8.05 ±
0.78%. There were no differences between the treatment modes in frequency ... Cited by 135 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org [PDF] EA Boland, M Grey, A Oesterle, L … - Diabetes Care, 1999 - Am Diabetes Assoc Continuous subcutaneous insulin infu- sion (CSII) via battery - powe red pumps
was introduced to treat type 1 diabetes 20 years ago (1,2). Although this appro
ach to insulin replacement provided a closer app roximation of normal ... Cited by 383 - Related articles - BL Direct - All 6 versions
JAH Ahern, EA Boland, R Doane, JJ Ahern, P … - Pediatric Diabetes, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 127 - Related articles - BL Direct - All 3 versions
AK Maniatis, GJ Klingensmith, RH Slover, … - Pediatrics, 2001 - Am Acad Pediatrics Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... From the
Barbara Davis Center for Childhood Diabetes, University of Colorado Health ... Cited by 143 - Related articles - All 5 versions
R Linkeschova, M Raoul, U Bott, M Berger, M … - Diabetic Medicine, 2002 - interscience.wiley.com MethodsOne hundred and three patients (58 women) started CSII between October
1995 and April 1999 in our department. The indication for CSII was optimization
of metabolic control and improvement of flexibility of life style (OF ... Cited by 85 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org EA Doyle, MSN APRN, SA Weinzimer, AT … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—While there was no significant change in the glargine group (HbA 1c
8.2% at baseline vs. 8.1% at 16 weeks), youth randomized to CSII had a sharp
reduction in HbA 1c levels, from 8.1 to 7.2% after 16 weeks of therapy (P < ... Cited by 170 - Related articles - BL Direct - All 9 versions
